COMPASS Pathways Total Long-Term Assets 2019-2024 | CMPS

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

COMPASS Pathways total long-term assets from 2019 to 2024. Total long-term assets can be defined as the sum of all assets classified as non-current

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

COMPASS Pathways total long-term assets from 2019 to 2024. Total long-term assets can be defined as the sum of all assets classified as non-current

Related Stocks
Company Name	Market Cap
Elevance Health (ELV)	$92.8B
Cencora (COR)	$49.5B
DiDi Global (DIDIY)	$22.6B
Natera (NTRA)	$22.2B
ICON (ICLR)	$16.3B
Revvity (RVTY)	$15B
Avantor (AVTR)	$14.6B
BioMerieux (BMXMF)	$14.2B
Viatris (VTRS)	$13.5B
CochLear (CHEOY)	$12.9B
Solventum (SOLV)	$12.9B
Doximity (DOCS)	$10.8B
Medpace Holdings (MEDP)	$10.7B
EUROFINS SCIENT (ERFSF)	$10.1B
HealthEquity (HQY)	$9.4B
Sonic Healthcare (SKHHY)	$8.7B
Charles River Laboratories (CRL)	$8.3B
Bausch + Lomb (BLCO)	$6.3B
Amplifon S.p.A (AMFPF)	$6.1B
BrightSpring Health Services (BTSG)	$4.1B
Organon (OGN)	$4.1B
Sotera Health (SHC)	$3.9B
Surgery Partners (SGRY)	$3.3B
Concentras Parent (CON)	$3B
Alignment Healthcare (ALHC)	$2.9B
Premier (PINC)	$2.2B
Ardent Health Partners (ARDT)	$2.1B
PACS (PACS)	$2.1B
GeneDx Holdings (WGS)	$2.1B
Progyny (PGNY)	$2B